Investor · Cambridge, MA

Thomas J. Schuetz

Open Thomas in the network graph →

Filings

41

SEC Form D

Connections

171

co-filers

Capital

$255.8M

across filings

Active

Apr 2019

to Jan 2025

Most-connected co-filers (171)

C J. Koomen · Santa Clara, CA13 shared John B. Kenworthy · Portsmouth, NH13 shared Randall R. Meals · Colorado Springs, CO13 shared John M. Soininen · Portsmouth, NH13 shared Jean-Louis Bories · Santa Clara, CA13 shared C.N Reddy · Santa Clara, CA13 shared Meryl Rains · Santa Clara, CA12 shared John Kent · Commack, NY12 shared Ivan Faggen · Los Angeles, CA12 shared James Jones · San Francisco, CA12 shared James M. Bethmann · Annapolis, MD11 shared Peter W. Cohn · Menlo Park, CA11 shared Vered P. Bisker-Leib · Cambridge, MA8 shared Philip Ferneau · Portland, ME7 shared Jonathan T. Silverstein · New York, NY7 shared Carl L. Gordon · New York, NY7 shared Jonathan Silverstein · Santa Clara, CA7 shared Stephen Squinto · HANOVER, NH6 shared Ronald O'Hanley · El Segundo, CA5 shared Jerry Buysse · South San Francisco, CA5 shared Jeremy J. Liew · Menlo Park, CA5 shared Scott Rocklage · South San Francisco, CA5 shared Gerrit Klaerner · South San Francisco, CA5 shared Thomas K. Spann · Plymouth Meeting, PA5 shared

Recent filings (41)

22 Holdings, LLCJan 2025 · 5 co-filers$6.0M 22 Holdings, LLCDec 2023 · 5 co-filers$6.0M Hatteras Venture Partners VI, LPOct 2020 · 22 co-filers$250.0M Compass Therapeutics, Inc.Jul 2020 · 17 co-filers$70.0M Compass Therapeutics, Inc.Jul 2020 · 17 co-filers$195.3M 22 Holdings, LLCApr 2019 · 7 co-filers$2.3M Hatteras Venture Partners VI, LPApr 2019 · 22 co-filers$250.0M Compass Therapeutics LLCJan 2018 · 39 co-filers$50.0M Compass Therapeutics LLCSep 2016 · 14 co-filers$170.2M Compass Therapeutics LLCSep 2016 · 14 co-filers$170.2M Park Ainslie LLCDec 2015 · 3 co-filers$1.0M Audentes Therapeutics, Inc.Oct 2015 · 22 co-filers$65.0M Audentes Therapeutics, Inc.Sep 2015 · 22 co-filers Compass Therapeutics LLCJul 2015 · 16 co-filers$121.0M Compass Therapeutics LLCJul 2015 · 16 co-filers$121.0M Audentes Therapeutics, Inc.Dec 2014 · 13 co-filers$42.5M 1944 Spaulding, LLCJan 2014 · 3 co-filers$1.0M Relypsa IncDec 2012 · 21 co-filers$80.0M Relypsa IncOct 2012 · 23 co-filers$80.0M Relypsa IncAug 2012 · 25 co-filers$80.0M Arteaus Therapeutics, LLCJul 2012 · 3 co-filers$18.0M Enobia Pharma CorpAug 2011 · 10 co-filers$40.0M Relypsa IncAug 2011 · 17 co-filers$70.1M Arteaus Therapeutics, LLCJul 2011 · 2 co-filers$18.0M XCEIVE CORPJun 2011 · 11 co-filers$1.6M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Thomas in the interactive graph →